AOD-9604 (5mg)

SGD 220.00

Product Name: AOD-9604
Specification: 5mg/vial
Purity: ≥ 99%
Form: Lyophilized powder
Storage: Store at -20°C in a cool, dry environment

👥Target Users:
✔️ Fitness and body transformation specialists
✔️ Wellness and anti-aging centers
✔️ Aesthetic medical clinics and beauty hospitals
✔️ Peptide sourcing agents and global resellers
✔️ Laboratories focused on body regulation studies

Product Name: AOD-9604
Specification: 5mg/vial
Purity: ≥ 99%
Form: Lyophilized powder
Storage: Store at -20°C in a cool, dry environment

👥Target Users:
✔️ Fitness and body transformation specialists
✔️ Wellness and anti-aging centers
✔️ Aesthetic medical clinics and beauty hospitals
✔️ Peptide sourcing agents and global resellers
✔️ Laboratories focused on body regulation studies

Quick Start Highlight

AOD‑9604 is a synthetic peptide derived from a fragment of human growth hormone (HGH), specifically amino acids 177–191 of the HGH molecule. It was originally developed as a potential anti-obesity drug due to its ability to influence fat metabolism without causing the same growth-promoting effects associated with full HGH therapy.

Unlike traditional HGH, AOD‑9604 does not significantly affect insulin-like growth factor 1 (IGF‑1) levels, meaning it was designed to stimulate fat breakdown without driving excess muscle growth or other unwanted hormonal changes.

Benefits of AOD-9604

May Support Fat Breakdown (Lipolysis)

  • AOD‑9604 mimics a small fragment of human growth hormone (HGH), specifically the region responsible for fat metabolism. Research suggests it may stimulate lipolysis — the process of breaking down stored fat into usable energy.
    However, results are dose-dependent and more effective when combined with a calorie-controlled diet or exercise program 

    Could Help Prevent Fat Storage (Reduced Lipogenesis)

  • Some animal studies suggest AOD‑9604 may limit the formation of new fat cells, known as lipogenesis (preclinical evidence). While this hasn’t been strongly replicated in humans, it could play a supporting role in long-term weight maintenance when combined with healthy habits.

    Less Risk of Hormonal Disruption

  • Unlike HGH therapy, AOD‑9604 doesn’t significantly affect IGF‑1 levels or alter broader endocrine function. This makes it less likely to cause systemic side effects like water retention, insulin resistance, or abnormal growth of tissues.

Where Marketing Goes Too Far

While AOD‑9604 has potential, many advertised claims overpromise its capabilities:

  • Spot Fat Reduction → There is no credible evidence AOD‑9604 specifically targets belly fat, love handles, or “problem areas.”

  • Dramatic Weight Loss Without Effort → No human trials support the idea of losing significant weight without changes in diet or activity.

  • Metabolism Boosting → While AOD‑9604 may subtly improve energy usage, it doesn’t “supercharge” metabolic rate.

Making It Relatable

Think of AOD‑9604 like a supporting actor in a movie — it can assist fat loss but can’t carry the whole show on its own. If your nutrition is unbalanced and activity levels are low, AOD‑9604 likely won’t deliver dramatic results. But when combined with:

  •  A structured, high-protein diet

  •  A smart training program

  • Other peptides or supplements with proven efficacy

it can potentially enhance your fat-loss efforts, especially during recomposition phases.

How Does AOD-9604 works?

AOD‑9604 mimics the way natural HGH regulates fat metabolism, but it targets lipolysis (fat breakdown) specifically, while having minimal impact on glucose regulation or protein synthesis. It does this by:

- Activating beta-3 adrenergic receptors → stimulates fat breakdown and mobilization
- Enhancing lipolysis → promotes the use of stored fat as energy
- Inhibiting lipogenesis → reduces the formation of new fat cells

In early studies, researchers observed that AOD‑9604 may help increase fat oxidation and improve metabolic flexibility, especially in overweight or obese individuals.

Potential Side Effects

  • Injection site reactions - Redness, itching, or mild swelling may appear, especially if rotation of injection sites is inconsistent.

  • Mild nausea or bloating - Occasionally reported when dosing begins but often subsides after a few days.

  • Fatigue or headaches - Rare but can occur in individuals sensitive to peptides affecting metabolic pathways.

Dosing & Reconstitution Guide

Educational guide for reconstitution and weekly dosing